2.40
price down icon0.41%   -0.01
after-market Handel nachbörslich: 2.42 0.02 +0.83%
loading
Schlusskurs vom Vortag:
$2.41
Offen:
$2.39
24-Stunden-Volumen:
76,137
Relative Volume:
0.52
Marktkapitalisierung:
$3.91M
Einnahmen:
$10.48M
Nettoeinkommen (Verlust:
$-37.74M
KGV:
-0.1483
EPS:
-16.1846
Netto-Cashflow:
$-29.03M
1W Leistung:
+0.00%
1M Leistung:
-14.29%
6M Leistung:
-88.45%
1J Leistung:
-97.75%
1-Tages-Spanne:
Value
$2.3202
$2.4399
1-Wochen-Bereich:
Value
$2.27
$2.51
52-Wochen-Spanne:
Value
$2.27
$57.00

Jaguar Health Inc Stock (JAGX) Company Profile

Name
Firmenname
Jaguar Health Inc
Name
Telefon
415-371-8300
Name
Adresse
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Name
Mitarbeiter
49
Name
Twitter
@Jaguar_Health
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
JAGX's Discussions on Twitter

Vergleichen Sie JAGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JAGX
Jaguar Health Inc
2.40 3.18M 10.48M -37.74M -29.03M -16.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-07-07 Eingeleitet Cantor Fitzgerald Overweight
2017-07-11 Eingeleitet Rodman & Renshaw Buy

Jaguar Health Inc Aktie (JAGX) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Jaguar Health Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Jaguar Health Inc. a good long term investmentAccelerated profit realization - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Jaguar Health Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Jaguar Health Inc. stock priceTremendous return on equity - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Form DEF 14A Jaguar Health, Inc. For: Aug 19 - StreetInsider

Jul 21, 2025
pulisher
Jul 20, 2025

Published on: 2025-07-20 16:31:40 - Autocar Professional

Jul 20, 2025
pulisher
Jul 16, 2025

Jaguar Health Announces Amendment to March 2020 Equity Purchase Agreement with Oasis Capital, LLC - FinancialContent

Jul 16, 2025
pulisher
Jul 11, 2025

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Lancaster Eagle-Gazette

Jul 11, 2025
pulisher
Jul 10, 2025

Clinical Trial Launches for First FDA-Approved Dog Diarrhea Treatment, Targeting $6B Pet Health Market - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Jaguar Health Eliminates Certain Royalty Obligations Reducing Future COGS for Mytesi and Crofelemer - ACCESS Newswire

Jul 09, 2025
pulisher
Jul 08, 2025

Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS In - El Paso Times

Jul 08, 2025
pulisher
Jul 08, 2025

Groundbreaking Deal: Peru Grants Access to Sacred Coca Plant for Mental Health Drug Research - Stock Titan

Jul 08, 2025
pulisher
Jul 07, 2025

Investors Give Jaguar Health, Inc. (NASDAQ:JAGX) Shares A 36% Hiding - 富途牛牛

Jul 07, 2025
pulisher
Jul 05, 2025

Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review - ACCESS Newswire

Jul 05, 2025
pulisher
Jul 04, 2025

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Lohud

Jul 04, 2025
pulisher
Jul 02, 2025

Investors Give Jaguar Health, Inc. (NASDAQ:JAGX) Shares A 43% Hiding - simplywall.st

Jul 02, 2025
pulisher
Jun 30, 2025

Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient - Worcester Telegram

Jun 30, 2025
pulisher
Jun 30, 2025

Breakthrough Treatment Reduces Parenteral Nutrition by 27% in Orphan Disease PatientsNew Clinical Data - Stock Titan

Jun 30, 2025
pulisher
Jun 27, 2025

Jaguar Health (JAGX) Announces $3.37M At-The-Market Stock Offering | JAGX SEC FilingForm 424B5 - Stock Titan

Jun 27, 2025
pulisher
Jun 26, 2025

Jaguar Health (JAGX) Adopts Cryptocurrency as Treasury Asset | JAGX Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Jaguar Health considers cryptocurrency for treasury reserves - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

Jaguar Health (JAGX) Targets EU Approval for Canalevia in Dogs | - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Jaguar Health (JAGX) Targets EU Approval for Canalevia in Dogs | JAGX Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Jaguar Health Targets 104M Dog EU Market with Novel Diarrhea Treatment as Partnership Talks Heat Up - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 - The Columbus Dispatch

Jun 24, 2025
pulisher
Jun 24, 2025

Jaguar Health extends maturity date for $2.57 million in notes By Investing.com - Investing.com Nigeria

Jun 24, 2025
pulisher
Jun 23, 2025

Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer - The Holland Sentinel

Jun 23, 2025
pulisher
Jun 23, 2025

Jaguar Health reports 25% enrollment in phase 2 MVID study - Investing.com

Jun 23, 2025
pulisher
Jun 18, 2025

Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts - Marco Eagle

Jun 18, 2025
pulisher
Jun 17, 2025

Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts | JAGX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Jaguar Health CEO Reveals Near-Term Catalysts at Emerging Growth Conference Tomorrow - Stock Titan

Jun 17, 2025

Finanzdaten der Jaguar Health Inc-Aktie (JAGX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):